Physician profile
Vishal Patel
NPI 1619313475
$23,209.82
in general payments reported to CMS, 2019-2025
24 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,042 · 2020: $1,524 · 2021: $1,259 · 2022: $2,907 · 2023: $2,169 · 2024: $2,536 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,535 · Consulting Fee: $4,425 · Travel and Lodging: $3,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,534.59 |
| Consulting Fee | $4,425.00 |
| Travel and Lodging | $3,518.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,576.27 | 2019-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $7,762.69 | 2021-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $1,421.46 | 2022 | |
| Si-Bone, INC. | $1,105.42 | 2024-2025 | |
| Medtronic, INC. | $950.71 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Bioventus LLC | $517.33 | 2025 | Stimrouter Implantable Kit |
| Nalu Medical, INC. | $415.21 | 2021-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $398.30 | 2019-2025 | Intracept |
| Mml US, INC. | $373.53 | 2022-2025 | Reactiv8 |
| Gilead Sciences, INC. | $301.08 | 2020-2024 | |
| Vertos Medical, INC. | $263.56 | 2019-2022 | |
| Nevro Corp. | $258.79 | 2021-2023 | Senza |
| Curonix LLC | $177.27 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $169.15 | 2023-2024 | Evoke Scs, Evoke |
| Stryker Corporation | $157.58 | 2025 | Mild Device Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $130.00 | 2021 | |
| Tersera Therapeutics LLC | $58.15 | 2019 | |
| Collegium Pharmaceutical, INC. | $37.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.90 | 2019 | |
| Medtronic USA, INC. | $28.54 | 2019 | |
| Amgen INC. | $27.30 | 2019 | |
| Spinal Simplicity, LLC | $18.49 | 2025 | Ha Minuteman G3-R |
| Daiichi Sankyo INC. | $17.47 | 2019 | |
| Sight Sciences, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.